LinkedInXFacebook
Subscribe
Orthopedics This Week
  • My Feed
  • |Posts
  • |Events
  • |MSK Innovations
  • |Power Rankings
  • |Masterclasses
  • |Technology Awards
  • Press Releases
  • |Advertising
  • |Job Board
  • Spine
  • ◆Joints
  • ◆Upper Extremities
  • ◆Foot & Ankle
  • ◆Sports Medicine
  • ◆Pain Mgmt
  • ◆Trauma
  • ◆Biologics
  • ◆Technology
  • ◆People
  • ◆Company News
  • ◆Legal & Regulatory
Home/Large Joints and Extremities/Local Infiltration Analgesia Is a Mixed Bag
Large Joints and Extremities

Local Infiltration Analgesia Is a Mixed Bag

July 25, 2022 2 min read Premium comments

Advertisement

#shoulderarthroplastySecondary#analgesis#interscaleneblock

Less costly local infiltration analgesia offers similar pain relief as interscalene block in the first 24 hours after shoulder arthroplasty, but more pain after 8 hours and more intraoperative opioid consumption, according to a new study.

The study, “Local Infiltration Analgesia Versus Interscalene Block for Pain Management,” was published online on July 1, 2022, in The Journal of Bone and Joint Surgery.

“While providing effective analgesia following shoulder arthroplasty, an interscalene block has known complications. Local infiltration analgesia using ropivacaine has been successfully employed in other joint arthroplasties, but its efficacy in shoulder arthroplasty has not been studied extensively,” the researchers wrote.

Their study compared pain and opioid consumption between local infiltration analgesia and an interscalene block following primary shoulder arthroplasty. Seventy-four patients were randomized to one of the two research arms. The interscalene block used liposomal bupivacaine and the local infiltration analgesia injection included ropivacaine, epinephrine, ketorolac, and normal saline solution.

The researchers compared postoperative Visual Analog Scale pain scores, opioid consumption in morphine milligram equivalents and complications for the two groups. They used the mean pain scores during the first 24 hours postoperatively to test noninferiority of local infiltration analgesia against an interscalene block.

Data showed no significant difference between the two groups with respect to pain scores at any particular time point, except at the 8-hour time point. At this time point, the injection group had a higher pain score (p = 0.01). There was no significant difference in opioid consumption after surgery between the groups at all; however, intraoperative opioid consumption was higher in the injection group (p < 0.001).

Complications reported included one patient in the bloc group who developed transient phrenic nerve palsy and one patient in the injection group who developed dislocation after reverse arthroplasty due to noncompliance.

The noninferiority test showed that the injection group was noninferior to the block group. The mean procedure hospital charge was $1,718 for an interscalene block and $157 for local infiltration analgesia.

Advertisement

“Local infiltration analgesia and an interscalene block provided similar analgesia during the first 24 hours after primary shoulder arthroplasty. Local infiltration analgesia was associated with worse pain at 8 hours postoperatively and more intraoperative opioid consumption but was also substantially less costly,” the researchers wrote.

The clinical trial investigators included Michael Ewing, M.D., Haley Huff, B.S., Sally Heil, B.S., Matthew J. Smith, M.D., and H. Mike Kim, M.D., all from the Missouri Orthopaedic Institute of the University of Missouri in Columbia, Missouri. Robert R. Borsheski, D.O, of the department of Anesthesiology at the University of Missouri also contributed to the study.

React:

Discussion

14
DS
Dr. Sarah MitchellOrthopedic Surgeon · Mayo Clinic

This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?

8
JT
James Thornton, MDSpine Fellow · HSS

Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.

5
RP
R. PatelSports Medicine · Stanford

We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.

Join the conversation

Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.

Subscribe

Get Full Access

Read every OTW article and join member discussions for $24.99/month.

Get Full Access

Advertisement

Advertisement

Advertisement

Orthopedics This Week

The most trusted source in orthopedic industry news since 2005. Covering spine, joints, trauma, biologics, and the business of orthopedics.

A publication of RRY Publications, LLC

LinkedInXFacebook

Categories

  • Spine
  • Joints
  • Upper Extremities
  • Foot & Ankle
  • Sports Medicine
  • Pain Mgmt
  • Trauma
  • Biologics
  • Technology
  • People
  • Company News
  • Legal & Regulatory

Resources

  • Subscribe
  • Community Posts
  • Job Board
  • Press Release Opportunities
  • Power Rankings
  • About OTW
  • Advertise
  • Contact Us

Get Full Access

Unlimited articles, community posts, and Power Rankings.

Get Full Access

Plans start at $24.99/mo · Annual saves 20%

© 2026 Orthopedics This Week · RRY Publications, LLC

Privacy PolicyTerms of ServiceCookie Policy